Abstract
DNA methylation patterns are often altered in human cancer and aberrant methylation is considered a hallmark of malignant transformation. Several methods have been developed for the characterization of gene-specific and genome-wide DNA methylation patterns. In this chapter, we describe the methylated-CpG island recovery assay (MIRA), which is based on the high affinity of the MBD2b/MBD3L1 complex for double-stranded CpG-methylated DNA. MIRA has been used in combination with microarray platforms to map DNA methylation patterns across the human genome.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Jones, P. A., Baylin, S. B. (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3, 415–428.
Bird, A. P. (1986) CpG-rich islands and the function of DNA methylation. Nature 321, 209–213.
Pfeifer, G. P. (2006) Mutagenesis at methylated CpG sequences. Curr Top Microbiol Immunol 301, 259–281.
Esteller, M. (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8, 286–298.
Costello, J. F., Fruhwald, M. C., Smiraglia, D. J., et al. (2000) Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 24,132–138.
Ushijima, T., Morimura, K., Hosoya, Y., et al. (1997) Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors. Proc Natl Acad Sci USA 94, 2284–2289.
Yan, P. S., Chen, C. M., Shi, H., et al. (2001) Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. Cancer Res 61, 8375–8380.
Sato, N., Fukushima, N., Maitra, A., et al. (2003) Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res 63, 3735–3742.
Shi, H., Wei, S. H., Leu, Y. W., et al. (2003) Triple analysis of the cancer epigenome: an integrated microarray system for assessing gene expression, DNA methylation, and histone acetylation. Cancer Res 63, 2164–2171.
Suzuki, H., Gabrielson, E., Chen, W., et al. (2002) A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31, 141–149.
Yamashita, K., Upadhyay, S., Osada, M., et al. (2002) Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. Cancer Cell 2, 485–495.
Weber, M., Davies, J. J., Wittig, D., et al. (2005) Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 37, 853–862.
Lippman, Z., Gendrel, A. V., Colot, V., et al. (2005) Profiling DNA methylation patterns using genomic tiling microarrays. Nat Methods 2, 219–224.
Nouzova, M., Holtan, N., Oshiro, M. M., et al. (2004) Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarrays. J Pharmacol Exp Ther 311, 968–981.
Taylor, K. H., Kramer, R. S., Davis, J. W., et al. (2007) Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res 67, 8511–8618.
Hendrich, B., Bird, A. (1998) Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 18, 6538–6547.
Rauch, T., Li, H., Wu, X., et al. (2006) MIRA-assisted microarray analysis, a new technology for the determination of genome-wide DNA methylation patterns, identifies frequent methylation of homeodomain containing genes in lung cancer cells. Cancer Res 66, 7939–7947.
Rauch, T., Pfeifer, G. P. (2005) Methylated-CpG island recovery assay: a new technique for the rapid detection of methylated-CpG islands in cancer. Lab Invest 85,172–180.
Rauch, T., Wang, Z., Zhang, X., et al. (2007) Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc Natl Acad Sci USA 104, 5527–5532.
Jiang, C. L., Jin, S. G., Pfeifer, G. P. (2004) MBD3L1 is a transcriptional repressor that interacts with MBD2 and components of the NuRD complex. J Biol Chem 279, 52456–52464.
Fraga, M. F., Ballestar, E., Montoya, G., et al. (2003) The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic Acids Res 31, 1765–1774.
Swords, W. E. (2003) Chemical transformation ofE. coli. Methods Mol Biol 235, 49–55.
Bickley, J., Owen, R. J. (1995) Preparation of bacterial genomic DNA. Methods Mol Biol 46, 141–148.
Selzer, R. R., Richmond, T, A, Pofahl, N. J., et al. (2005) Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH. Genes Chromosomes Cancer 44, 305–319.
Acknowledgements
This work was supported by NIH grants CA104967 and CA128495 to GPP.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Rauch, T.A., Pfeifer, G.P. (2009). The MIRA Method for DNA Methylation Analysis. In: Tost, J. (eds) DNA Methylation. Methods in Molecular Biology, vol 507. Humana Press. https://doi.org/10.1007/978-1-59745-522-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-59745-522-0_6
Publisher Name: Humana Press
Print ISBN: 978-1-934115-61-9
Online ISBN: 978-1-59745-522-0
eBook Packages: Springer Protocols